MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Orthofix Medical Long-Term Debt 2011-2026 | OFIX
Long-term debt is a financial obligation of a company or an individual with a repayment period exceeding one year from the date it arises. In accounting, such obligations are recorded under the "long-term liabilities" section.
Main characteristics:- Term exceeds 12 months
- Can take the form of bonds, bank loans, credit lines, leasing, or loans from affiliated parties
- Repaid through regular payments (interest and/or principal) over several years
- Investment in development
Allows financing of large projects — new factories, production lines, innovative developments — without diverting working capital. - Smoothing of cash flows
A long-term payment schedule facilitates budget planning and reduces short-term financial risks. - Optimization of capital structure
A combination of equity and borrowed capital can reduce the average cost of business financing.
A high level of long-term debt may indicate that a company heavily relies on borrowed funds. This increases risks, especially in conditions of rising interest rates or declining profits. However, a moderate level of debt can signal a sound growth strategy — for example, the company takes a loan to expand its business.
If a company uses borrowed funds effectively (e.g., invests in profitable projects), this can lead to profit growth and, consequently, an increase in stock value. An investor evaluates whether the investments made using debt are paying off.
It is important to monitor whether the company can regularly pay interest and repay the principal. Payment difficulties can lead to reduced dividends, a drop in stock value, and even bankruptcy.
Examples of long-term debt:- Mortgage loans for property purchases
- Corporate bonds issued by a company to raise capital
- Project financing — long-term loans for building or expanding production facilities
- Leasing obligations for equipment or transport
Annual Long-Term Debt Orthofix Medical
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 157 M | 93.1 M | 19.2 M | 19.9 M | - | - | - | - | - | - | - | 20 M | 20 M | 191 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 191 M | 19.2 M | 74.3 M |
Quarterly Long-Term Debt Orthofix Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 157 M | 157 M | 157 M | 157 M | 112 M | 113 M | 115 M | 93.1 M | 70 M | 51 M | 45 M | 19.2 M | 19.4 M | - | 19.7 M | 19.9 M | 20 M | 20.2 M | 20.3 M | 22.3 M | 22.3 M | 100 M | 22.3 M | 20.6 M | 20.6 M | 20.6 M | 20.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 157 M | 19.2 M | 62.2 M |
Long-Term Debt of other stocks in the Medical devices industry
| Issuer | Long-Term Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
32.7 M | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
2.93 K | - | 3.58 % | $ 2.21 M | USA |
 |
AxoGen
AXGN
|
47.5 M | $ 32.5 | -8.14 % | $ 1.44 B | USA |
 |
Bio-Rad Laboratories
BIO
|
1.2 B | $ 269.87 | 0.53 % | $ 7.61 B | USA |
 |
Apollo Endosurgery
APEN
|
34 M | - | - | $ 475 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
71.3 M | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
575 M | $ 13.77 | 4.86 % | $ 1.97 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
430 K | - | -5.86 % | $ 30.6 M | USA |
 |
Avinger
AVGR
|
1.1 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
3.01 M | $ 14.58 | -1.22 % | $ 394 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
7.56 M | - | - | $ 3.31 B | USA |
 |
Apyx Medical Corporation
APYX
|
33.2 M | $ 3.53 | -1.12 % | $ 122 M | USA |
 |
Aziyo Biologics
AZYO
|
20.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
24.1 M | $ 6.36 | 0.32 % | $ 457 M |  Israel |
 |
BIOLASE
BIOL
|
11.8 M | - | -13.19 % | $ 166 K | USA |
 |
Bruker Corporation
BRKR
|
2.06 B | $ 39.87 | 0.77 % | $ 5.94 K | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
11.1 B | $ 75.27 | 1.21 % | $ 111 B | USA |
 |
EDAP TMS S.A.
EDAP
|
2.16 M | $ 4.52 | - | $ 169 M |  France |
 |
Electromed
ELMD
|
1.1 M | $ 23.17 | -5.16 % | $ 196 M | USA |
 |
CryoLife, Inc.
CRY
|
290 M | - | -4.14 % | $ 702 M | USA |
 |
Conformis
CFMS
|
20.6 M | - | - | $ 16.4 M | USA |
 |
CONMED Corporation
CNMD
|
834 M | $ 46.0 | 1.39 % | $ 1.43 B | USA |
 |
Itamar Medical Ltd.
ITMR
|
154 K | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
38.6 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
7.64 M | - | - | $ 111 M |  Canada |
 |
Cardiovascular Systems
CSII
|
1.33 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
1.06 M | - | -10.19 % | $ 1.99 M | USA |
 |
Delcath Systems
DCTH
|
10.2 M | $ 9.94 | 2.0 % | $ 283 M | USA |
 |
Intersect ENT, Inc.
XENT
|
63.6 M | - | - | $ 955 M | USA |
 |
Eargo
EAR
|
11.9 M | - | - | $ 10.2 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.11 M | - | 14.99 % | $ 929 K | USA |
 |
IRadimed Corporation
IRMD
|
1.42 K | $ 99.04 | -2.22 % | $ 1.25 B | USA |
 |
Establishment Labs Holdings
ESTA
|
220 M | $ 78.78 | 5.1 % | $ 2.22 B |  Costa-rica |
 |
Second Sight Medical Products
EYES
|
18 M | - | -0.97 % | $ 54.4 M | USA |
 |
LivaNova PLC
LIVN
|
550 M | $ 69.26 | 1.32 % | $ 3.76 B |  Britain |
 |
FONAR Corporation
FONR
|
155 K | $ 18.55 | -0.22 % | $ 122 M | USA |
 |
GBS
GBS
|
1.65 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
298 K | $ 92.25 | -1.25 % | $ 12.5 B | USA |
 |
Myomo
MYO
|
200 K | $ 0.67 | -3.42 % | $ 4.72 M | USA |
 |
Helius Medical Technologies
HSDT
|
12 K | $ 1.88 | - | $ 1.14 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
760 M | $ 11.57 | -1.66 % | $ 891 M | USA |
 |
MiMedx Group
MDXG
|
17.8 M | $ 5.35 | 0.28 % | $ 786 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
3.48 M | $ 2.42 | 2.17 % | $ 142 M | Israel |
 |
Inogen
INGN
|
16.6 M | $ 5.72 | 0.7 % | $ 135 M | USA |